Extract from the Register of European Patents

EP Citations: EP2289492

Cited inSearch
Type:Patent literature
Publication No.:WO0062757  [I]
 (BRITANNIA PHARMACEUTICALS LTD [GB], et al) [I] 1-6,9,10 * page 2, lines 11-16 * * page 3, lines 11-16, 21,22 *;
Type:Patent literature
Publication No.:WO0185257  [I]
 (PAIN THERAPEUTICS INC [US], et al) [I] 1-10 * page 33, lines 1-12 * * page 33, line 29 - page 34, line 5 * * page 24, line 21 - page 25, line 9 * * page 1, lines 12-15 *;
Type:Non-patent literature
Publication information:[AP]  - "Guideline on Stability Testing of Existing Active Substances and Related Finished Products", (20031217), pages 1 - 18, EMEA, URL: http://www.emea.europa.eu/pdfs/human/qwp/012202en.pdf, (20080626), XP002662653 [AP] 9,10
Type:Non-patent literature
Publication information:[A]  - FERRARI ANNA ET AL, "Serum time course of naltrexone and 6beta-naltrexol level during long term treatment in drug addicts", DRUG AND ALCOHOL DEPENDENCE, (19981101), vol. 52, no. 3, ISSN 0376-8716, pages 211 - 220, XP002400472 [A] 1-10 * the whole document *
DOI: http://dx.doi.org/10.1016/S0376-8716(98)00098-2
Cited inby applicant
Type:Patent literature
Publication No.:US3332950  
Type:Patent literature
Publication No.:US5472943  
Type:Patent literature
Publication No.:US5512578  
Type:Patent literature
Publication No.:US5580876  
Type:Patent literature
Publication No.:US5767125  
Type:Patent literature
Publication No.:EP0880352  
Type:Patent literature
Publication No.:WO0158451  
Type:Patent literature
Publication No.:US6277384  
Type:Non-patent literature
Publication information:   - GONZALEZ J P ET AL., "Naltrexone: A review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Efficacy in the Management of Opioid Dependence", DRUGS, (1988), vol. 35, pages 192 - 213
Type:Non-patent literature
Publication information:   - REVIA, Physician's Desk Reference
Type:Non-patent literature
Publication information:   - MEDICAL ECONOMICS, (1997), vol. 51, pages 957 - 959
Type:Patent literature
Publication No.:US20020364521